Literature DB >> 9025680

Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro.

D De1, F M Krogstad, F B Cogswell, D J Krogstad.   

Abstract

Aminoquinoline (AQ) resistance is one of the most important factors in the worldwide resurgence of malaria due to Plasmodium falciparum. We synthesized a series of AQs to define the structure-activity relationships responsible for AQ action against chloroquine-susceptible and -resistant P. falciparum. The AQs with ethyl, propyl, isopropyl, butyl, pentyl, isopentyl (chloroquine), hexyl, octyl, decyl, or dodecyl side chains were equally active against chloroquine-susceptible P. falciparum (50% inhibitory concentrations [IC50s] = 5-15 nM). The AQs with ethyl, propyl, isopropyl, decyl, or dodecyl side chains were also active against chloroquine-, mefloquine- and multiply-resistant P. falciparum (IC50s = 5-20 nM). Verapamil, which enhances the activity of chloroquine against chloroquine-resistant parasites, had no effect on the activity of AQs that were active against resistant parasites. These results indicate that AQs with 2-12 carbon side chains are as active as chloroquine against chloroquine-susceptible P. falciparum, and that AQs with side chains shorter or longer than chloroquine are often active against chloroquine-, mefloquine-, and multiply-resistant P. falciparum.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9025680     DOI: 10.4269/ajtmh.1996.55.579

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  35 in total

1.  Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance.

Authors:  D A Fidock; T Nomura; A K Talley; R A Cooper; S M Dzekunov; M T Ferdig; L M Ursos; A B Sidhu; B Naudé; K W Deitsch; X Z Su; J C Wootton; P D Roepe; T E Wellems
Journal:  Mol Cell       Date:  2000-10       Impact factor: 17.970

2.  Computational studies of new potential antimalarial compounds--stereoelectronic complementarity with the receptor.

Authors:  César Portela; Carlos M M Afonso; Madalena M M Pinto; Maria João Ramos
Journal:  J Comput Aided Mol Des       Date:  2003-09       Impact factor: 3.686

3.  Lipophilic mediated assays for beta-hematin inhibitors.

Authors:  Melissa D Carter; Vanessa V Phelan; Rebecca D Sandlin; Brian O Bachmann; David W Wright
Journal:  Comb Chem High Throughput Screen       Date:  2010-03       Impact factor: 1.339

Review 4.  Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics.

Authors:  Robert L Summers; Megan N Nash; Rowena E Martin
Journal:  Cell Mol Life Sci       Date:  2012-06       Impact factor: 9.261

5.  Incorporation of an intramolecular hydrogen-bonding motif in the side chain of 4-aminoquinolines enhances activity against drug-resistant P. falciparum.

Authors:  Peter B Madrid; Ally P Liou; Joseph L DeRisi; R Kiplin Guy
Journal:  J Med Chem       Date:  2006-07-27       Impact factor: 7.446

6.  Synthesis and antimalarial activity of new 4-amino-7-chloroquinolyl amides, sulfonamides, ureas and thioureas.

Authors:  Kekeli Ekoue-Kovi; Kimberly Yearick; Daniel P Iwaniuk; Jayakumar K Natarajan; John Alumasa; Angel C de Dios; Paul D Roepe; Christian Wolf
Journal:  Bioorg Med Chem       Date:  2008-11-12       Impact factor: 3.641

7.  Optimization of xanthones for antimalarial activity: the 3,6-bis-omega-diethylaminoalkoxyxanthone series.

Authors:  Jane Xu Kelly; Rolf Winter; David H Peyton; David J Hinrichs; Michael Riscoe
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

8.  Synthesis and antimalarial activity of new chloroquine analogues carrying a multifunctional linear side chain.

Authors:  Daniel P Iwaniuk; Eric D Whetmore; Nicholas Rosa; Kekeli Ekoue-Kovi; John Alumasa; Angel C de Dios; Paul D Roepe; Christian Wolf
Journal:  Bioorg Med Chem       Date:  2009-08-08       Impact factor: 3.641

Review 9.  Recent updates in the discovery and development of novel antimalarial drug candidates.

Authors:  John Okombo; Kelly Chibale
Journal:  Medchemcomm       Date:  2018-02-02       Impact factor: 3.597

Review 10.  Malaria biology and disease pathogenesis: insights for new treatments.

Authors:  Louis H Miller; Hans C Ackerman; Xin-zhuan Su; Thomas E Wellems
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.